This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 1170 |
| Fig | 714 |
| CoV | 535 |
| RNA | 462 |
| RSV | 437 |
| T | 420 |
| MERS | 416 |
| IBV | 409 |
| S | 385 |
| C | 361 |
| PCR | 350 |
| Health | 285 |
| VSV | 284 |
| A | 271 |
| CD8 | 245 |
| B | 245 |
| China | 236 |
| RBD | 236 |
| sera | 234 |
| COVID-19 | 226 |
| M | 218 |
| IFN- | 217 |
| PBS | 211 |
| ELISA | 209 |
| CoV-2 | 205 |
| Table | 201 |
| • | 200 |
| US | 200 |
| CD4 | 195 |
| M. | 188 |
| MVA | 185 |
| WNV | 177 |
| Vaccine | 176 |
| West | 173 |
| Nile | 158 |
| Fc | 157 |
| G | 156 |
| F | 148 |
| ␥ | 145 |
| L. | 141 |
| IgG | 140 |
| H1N1 | 140 |
| Ebola | 138 |
| RT | 135 |
| HIV | 134 |
| BCG | 134 |
| SIV | 133 |
| United | 132 |
| PRRSV | 132 |
| HA | 130 |
| N | 129 |
| S1 | 126 |
| PRRS | 126 |
| National | 126 |
| Vero | 125 |
| DNA | 123 |
| C. | 122 |
| USA | 120 |
| H5N1 | 120 |
| ALVAC | 120 |
| IgA | 116 |
| New | 114 |
| States | 113 |
| II | 113 |
| Influenza | 112 |
| PIKA | 108 |
| Mtb | 106 |
| East | 105 |
| World | 104 |
| UK | 104 |
| IFN | 103 |
| TGEV | 99 |
| WCL | 97 |
| Research | 97 |
| Africa | 97 |
| MVAIK | 96 |
| HIV-1 | 95 |
| IgM | 93 |
| MDCK | 91 |
| Europe | 89 |
| NK | 88 |
| Middle | 87 |
| H7N9 | 86 |
| S. | 85 |
| Immunization | 83 |
| WHO | 82 |
| Institute | 82 |
| sha | 80 |
| Japan | 78 |
| Disease | 78 |
| SPF | 77 |
| Australia | 76 |
| HLA | 76 |
| BeauR | 75 |
| Protollin | 75 |
| lactis | 73 |
| TR2 | 73 |
| MHC | 73 |
| Animal | 73 |
| ␣ | 72 |
| University | 72 |
| Sigma | 72 |
| Group | 72 |
| B. | 72 |
| ArkGA | 72 |
| M41(S | 70 |
| Ankara | 70 |
| EV71 | 70 |
| Rift | 70 |
| PDVAC | 70 |
| TCID | 70 |
| YZ | 70 |
| Development | 69 |
| Committee | 69 |
| ZIKV | 68 |
| Kong | 68 |
| Hong | 68 |
| ChAdOx1 | 68 |
| DENV | 67 |
| Center | 67 |
| CTL | 67 |
| BALB | 66 |
| CHO | 66 |
| rH120-S1 | 66 |
| TM | 64 |
| E | 64 |
| Organization | 64 |
| pH | 64 |
| Vaccination | 64 |
| Valley | 64 |
| MLV | 63 |
| ASP-1 | 63 |
| Safety | 60 |
| IVE | 60 |
| Coronavirus | 60 |
| Zika | 59 |
| Kunjin | 59 |
| J. | 59 |
| Control | 59 |
| vivo | 58 |
| EID | 58 |
| BEI | 57 |
| Human | 57 |
| L | 56 |
| Canada | 56 |
| Vaccines | 55 |
| NC | 55 |
| MV | 55 |
| Germany | 55 |
| CpG | 55 |
| CH | 55 |
| Brazil | 55 |
| M51-G | 54 |
| CDC | 54 |
| CK | 54 |
| Evaluation | 54 |
| Leishmune | 54 |
| VLP | 54 |
| P40 | 54 |
| U.S. | 54 |
| ® | 54 |
| anti | 54 |
| SDS | 53 |
| R | 53 |
| South | 53 |
| D | 52 |
| Asia | 52 |
| CA | 52 |
| DC | 52 |
| DOI | 52 |
| Dr. | 52 |
| EU | 52 |
| India | 52 |
| mg | 52 |
| hepatitis | 51 |
| Lister | 51 |
| Inc. | 51 |
| Global | 51 |
| ELISPOT | 51 |
| Beijing | 51 |
| IL-10 | 50 |
| Gag | 50 |
| PAGE | 50 |
| PT | 50 |
| H | 49 |
| FDA | 49 |
| QX | 49 |
| ICLC | 49 |
| Invitrogen | 49 |
| Prevention | 48 |
| Medical | 48 |
| France | 48 |
| BPL | 48 |
| BN | 48 |
| AIK | 48 |
| America | 47 |
| FCoV | 47 |
| H3N2 | 47 |
| Medicine | 47 |
| Singapore | 47 |
| VN | 47 |
| Zealand | 47 |
| Netherlands | 47 |
| kDa | 46 |
| IU | 46 |
| AOM | 46 |
| MSA2 | 45 |
| M51 | 45 |
| FMD | 45 |
| FAVN | 44 |
| BD | 44 |
| Herd | 44 |
| s.c | 44 |
| Department | 43 |
| HI | 43 |
| Mycobacterium | 43 |
| S377 | 43 |
| rHA | 43 |
| P70 | 42 |
| Immunogenicity | 42 |
| IgG2a | 42 |
| HCP | 42 |
| FIP | 42 |
| CI | 42 |
| Beaudette | 42 |
| ADE | 41 |
| Escherichia | 41 |
| H120 | 41 |
| ovo | 41 |
| Poly | 40 |
| NIH | 40 |
| E. | 40 |
| Advisory | 40 |
| i.m | 40 |
| ± | 39 |
| MLV+ | 39 |
| LC16m8 | 39 |
| International | 39 |
| EDA | 39 |
| EBOV | 39 |
| CP | 39 |
| Balb | 39 |
| A12-LLV2 | 38 |
| Brighton | 38 |
| Bordetella | 38 |
| Ad26 | 38 |
| Dr | 38 |
| MF59 | 38 |
| European | 38 |
| tPA | 38 |
| S2 | 37 |
| RTV | 37 |
| Guangzhou | 37 |
| Efficacy | 37 |
| Collaboration | 37 |
| Virus | 37 |
| Leishmania | 36 |
| Analysis | 36 |
| LHLJ/04V | 36 |
| CPE | 36 |
| Viral | 36 |
| Working | 36 |
| parainfluenza | 36 |
| rOv | 36 |
| flavivirus | 35 |
| WTP | 35 |
| PBST | 35 |
| IL-2 | 35 |
| HRP | 35 |
| FML | 35 |
| AMPV | 35 |
| A. | 35 |
| ESE | 34 |
| Beau | 34 |
| DCVMN | 34 |
| Dryvax | 34 |
| IFA | 34 |
|  | 34 |
| PEDV | 34 |
| Phase | 34 |
| Italy | 34 |
| OIE | 33 |
| Americas | 33 |
| IL-12 | 33 |
| ACE2 | 33 |
| P3 | 33 |
| PA | 33 |
| Program | 33 |
| Protein | 33 |
| rN | 32 |
| TLR7 | 32 |
| Resources | 32 |
| MPL | 32 |
| IL-4 | 32 |
| I | 32 |
| Care | 32 |
| Association | 32 |
| ml | 32 |
| Bio | 31 |
| DX | 31 |
| Flu | 31 |
| 3B | 31 |
| FA | 31 |
| Arabia | 31 |
| H. | 31 |
| Services | 31 |
| IL-6 | 31 |
| XN2 | 31 |
| DCE | 31 |
| Saudi | 31 |
| PID | 31 |
| aP | 30 |
| Veterinary | 30 |
| V3SWG | 30 |
| System | 30 |
| Sera | 30 |
| NT | 30 |
| NCI | 30 |
| Lyme | 30 |
| Freund | 30 |
| EMA | 29 |
| 3A | 29 |
| AIDS | 29 |
| Centers | 29 |
| Respiratory | 29 |
| H292 | 29 |
| Rabies | 29 |
| Use | 29 |
| HCWs | 28 |
| A(H1N1)pdm09 | 28 |
| AS03-adjuvanted | 28 |
| Aedes | 28 |
| Antibody | 28 |
| G. | 28 |
| Administration | 28 |
| LC16mO | 28 |
| nucleocapsid | 28 |
| Mycoplasma | 28 |
| p.i | 28 |
| CoV-1 | 28 |
| leprae | 28 |
| NITAG | 28 |
| Chitosan | 27 |
| Pasteur | 27 |
| PR8 | 27 |
| P1 | 27 |
| Ministry | 27 |
| England | 27 |
| Diseases | 27 |
| Council | 27 |
| CPV-2 | 27 |
| American | 27 |
| D. | 26 |
| CoV. | 26 |
| TLR | 26 |
| BMV | 26 |
| Laboratories | 26 |
| Hendra | 26 |
| VEE | 26 |
| Laboratory | 26 |
| Molecular | 26 |
| Protection | 26 |
| Sciences | 26 |
| UNICEF | 26 |
| Argentina | 25 |
| BSA | 25 |
| BSE | 25 |
| Food | 25 |
| MF | 25 |
| Gavi | 25 |
| OPV | 25 |
| State | 25 |
| TL | 25 |
| allantoic | 25 |
| gB | 25 |
| Public | 25 |
| Ltd. | 24 |
| BHK | 24 |
| DPC | 24 |
| Effectiveness | 24 |
| FBS | 24 |
| GEM | 24 |
| H5 | 24 |
| IgG1 | 24 |
| Institutes | 24 |
| K | 24 |
| Infectious | 24 |
| MMR | 24 |
| October | 24 |
| P. | 24 |
| P20 | 24 |
| Republic | 24 |
| SA | 24 |
| Taiwan | 24 |
| Vaccinia | 24 |
| YFV | 24 |
| N53 | 24 |
| EP | 23 |
| January | 23 |
| III | 23 |
| FLSC | 23 |
| FITC | 23 |
| ATCC | 23 |
| Clinical | 23 |
| CPV-2b | 23 |
| Arkansas | 23 |
| April | 23 |
| MD | 23 |
| LD | 23 |
| Syndrome | 23 |
| MN184 | 23 |
| Science | 23 |
| −/− | 23 |
| March | 23 |
| TLR-3 | 23 |
| Scientific | 23 |
| i.n | 23 |
| Rad | 23 |
| P60 | 23 |
| OVA | 23 |
| Network | 23 |
| Gibco | 22 |
| 293T | 22 |
| A549 | 22 |
| AS03 | 22 |
| Abstract | 22 |
| ArkDPI | 22 |
| BCoV | 22 |
| CEPI | 22 |
| DMEM | 22 |
| FMDV | 22 |
| Denmark | 22 |
| I. | 22 |
| Induction | 22 |
| R. | 22 |
| Study | 22 |
| White | 22 |
| antigen | 22 |
| herpes | 22 |
| lg | 22 |
| mRNA | 22 |
| IB | 22 |
| F11 | 21 |
| AMR | 21 |
| Assessment | 21 |
| BHK-21 | 21 |
| Biosciences | 21 |
| CMV | 21 |
| Centre | 21 |
| GFP | 21 |
| IPV | 21 |
| PRN | 21 |
| VAE | 21 |
| ZVL | 21 |
| i.p | 21 |
| virus | 21 |
| FHA | 20 |
| IC | 20 |
| H7 | 20 |
| GBS | 20 |
| Flavivirus | 20 |
| December | 20 |
| EP10 | 20 |
| Drug | 20 |
| June | 20 |
| DPP4 | 20 |
| Belgium | 20 |
| ISA | 20 |
| North | 20 |
| LAMP-1 | 20 |
| Supplementary | 20 |
| LE | 20 |
| rIBYZ | 20 |
| pgp | 20 |
| WT | 20 |
| kb | 20 |
| School | 20 |
| SCID | 20 |
| Plan | 20 |
| NP | 20 |
| MNC | 20 |
| Framework | 19 |
| Louis | 19 |
| Li | 19 |
| Lactococcus | 19 |
| July | 19 |
| Investigation | 19 |
| ILI | 19 |
| Anti | 19 |
| E6 | 19 |
| Day | 19 |
| Class | 19 |
| Chen | 19 |
| CD46 | 19 |
| ABI | 19 |
| MSA2-nCov | 19 |
| MOI | 19 |
| Tregs | 19 |
| Mucosal | 19 |
| Survey | 19 |
| OD | 19 |
| Zaire | 19 |
| Yamagata | 19 |
| −80 | 19 |
| Th1 | 19 |
| TaqMan | 19 |
| −20 | 19 |
| Sanofi | 19 |
| SAA | 19 |
| Review | 19 |
| Q | 19 |
| Placebo | 19 |
| PBL | 19 |
| SPV | 19 |
| CNS | 18 |
| H3 | 18 |
| GenBank | 18 |
| Foundation | 18 |
| Fisher | 18 |
| ER | 18 |
| EPI | 18 |
| Biological | 18 |
| CMI | 18 |
| C1q | 18 |
| Atlanta | 18 |
| Agency | 18 |
| Action | 18 |
| HSV | 18 |
| HEK293 | 18 |
| Information | 18 |
| Healthcare | 18 |
| Prism | 18 |
| ebola | 18 |
| WNVsyn | 18 |
| Hepatitis | 18 |
| Thailand | 18 |
| San | 18 |
| Salmonella | 18 |
| Vector | 18 |
| PriProET | 18 |
| PPD | 18 |
| P | 18 |
| Massachusetts | 18 |
| Kingdom | 18 |
| People | 18 |
| Dengue | 17 |
| Institutional | 17 |
| GraphPad | 17 |
| Government | 17 |
| Elsevier | 17 |
| CBER | 17 |
| CFA | 17 |
| CD21 | 17 |
| Biotech | 17 |
| Adenovirus | 17 |
| MTX | 17 |
| J | 17 |
| May | 17 |
| mAbs | 17 |
| Nipah | 17 |
| PBMC | 17 |
| RHDV | 17 |
| RPMI | 17 |
| S1-Fc | 17 |
| Union | 17 |
| VPD | 17 |
| splenocytes | 17 |
| Ò | 17 |
| N. | 17 |
| GlaxoSmithKline | 16 |
| F. | 16 |
| Filo | 16 |
| Identification | 16 |
| Hospital | 16 |
| Endo | 16 |
| Epidemic | 16 |
| August | 16 |
| CVI-78 | 16 |
| CD80 | 16 |
| CD3 | 16 |
| C3 | 16 |
| LSU | 16 |
| Aldrich | 16 |
| Korea | 16 |
| MHV | 16 |
| Liu | 16 |
| TPP | 16 |
| − | 16 |
| × | 16 |
| qRT | 16 |
| Victoria | 16 |
| Th | 16 |
| USDA | 16 |
| TBEV | 16 |
| SAGE | 16 |
| ResPlex | 16 |
| RRR | 16 |
| Product | 16 |
| PAHO | 16 |
| Indonesia | 15 |
| Programme | 15 |
| Preparedness | 15 |
| Novel | 15 |
| NIAID | 15 |
| M41 | 15 |
| London | 15 |
| Report | 15 |
| GNN | 15 |
| GM | 15 |
| Epidemiology | 15 |
| CD25 | 15 |
| Board | 15 |
| Ark | 15 |
| A*0201 | 15 |
| RHD | 15 |
| Plasmodium | 15 |
| Service | 15 |
| WNVwt | 15 |
| Spain | 15 |
| parvum | 15 |
| meta | 15 |
| intranasal | 15 |
| Western | 15 |
| Wang | 15 |
| York | 15 |
| VP60 | 15 |
| Tat | 15 |
| TGF- | 15 |
| TC-83 | 15 |
| Systems | 15 |
| protein | 15 |
| Surveillance | 15 |
| CR1 | 14 |
| JE | 14 |
| Inactivation | 14 |
| HPV | 14 |
| GA | 14 |
| Drs | 14 |
| Data | 14 |
| DTwP | 14 |
| CV1 | 14 |
| 2b | 14 |
| CP-1 | 14 |
| C57BL/6 | 14 |
| C3b | 14 |
| Biologicals | 14 |
| Academy | 14 |
| AR01 | 14 |
| 3C | 14 |
| MP-12 | 14 |
| 1C | 14 |
| JEV | 14 |
| K. | 14 |
| nan | 14 |
| T. | 14 |
| speci | 14 |
| simplex | 14 |
| i.d | 14 |
| hu | 14 |
| cytometric | 14 |
| Thermo | 14 |
| Th2 | 14 |
| TLR4 | 14 |
| TB | 14 |
| route | 14 |
| Sweden | 14 |
| Qiagen | 14 |
| Streptococcus | 14 |
| PCV | 14 |
| Practices | 14 |
| NIBSC | 14 |
| SP | 14 |
| September | 14 |
| Smallpox | 14 |
| F69 | 13 |
| M29 | 13 |
| LBV | 13 |
| Indian | 13 |
| Ig | 13 |
| IL | 13 |
| Georgia | 13 |
| Geneva | 13 |
| EMC2012 | 13 |
| Edmonston | 13 |
| MSA2-Cov | 13 |
| Diego | 13 |
| David | 13 |
| DCs | 13 |
| ClinicalTrials.gov | 13 |
| Brucella | 13 |
| Ark99 | 13 |
| MGB | 13 |
| Wuhan | 13 |
| NW | 13 |
| TLR3 | 13 |
| Office | 13 |
| ∼130 | 13 |
| poxvirus | 13 |
| ethylenimine | 13 |
| Uganda | 13 |
| UKVN | 13 |
| Tween | 13 |
| replicon | 13 |
| Software | 13 |
| Ontario | 13 |
| Recombinant | 13 |
| Poisson | 13 |
| Patient | 13 |
| PRNT | 13 |
| PPV23 | 13 |
| Shigella | 13 |
| Division | 12 |
| Epstein | 12 |
| Figure | 12 |
| Florida | 12 |
| Guangdong | 12 |
| IBYZ | 12 |
| LPS | 12 |
| NY | 12 |
| LAIV | 12 |
| Malaysia | 12 |
| Marburg | 12 |
| Mediterranean | 12 |
| Corporation | 12 |
| Corynebacterium | 12 |
| BVDV | 12 |
| Chi | 12 |
| Calmette | 12 |
| CVS-11 | 12 |
| CVL | 12 |
| CD86 | 12 |
| CD40 | 12 |
| CD28 | 12 |
| C3d | 12 |
| Americans | 12 |
| Adult | 12 |
| APC | 12 |
| ADV | 12 |
| 3a | 12 |
| 2C | 12 |
| Millipore | 12 |
| Rapid | 12 |
| ORF | 12 |
| Type | 12 |
| P110 | 12 |
| zoster | 12 |
| ug | 12 |
| swinepox | 12 |
| serologic | 12 |
| mL | 12 |
| lacZ | 12 |
| heterologous | 12 |
| bp | 12 |
| ankara | 12 |
| Yu | 12 |
| WSF | 12 |
| W. | 12 |
| lyssavirus | 12 |
| Transmission | 12 |
| Russia | 12 |
| Technical | 12 |
| PCMC | 12 |
| Pharmingen | 12 |
| R&D | 12 |
| Reagent | 12 |
| RTS | 12 |
| SRID | 12 |
| Serum | 12 |
| Switzerland | 12 |
| TBLN | 12 |
| TPA | 12 |
| Eastern | 11 |
| General | 11 |
| Effect | 11 |
| FACS | 11 |
| FIPV | 11 |
| GMP | 11 |
| GVAP | 11 |
| Gene | 11 |
| MA | 11 |
| HAI | 11 |
| Herds | 11 |
| IHD | 11 |
| Indiana | 11 |
| La | 11 |
| M2 | 11 |
| MO | 11 |
| D1466 | 11 |
| Detection | 11 |
| AEI | 11 |
| Coalition | 11 |
| Chinese | 11 |
| < | 11 |
| A2.1 | 11 |
| ACIP | 11 |
| Meeting | 11 |
| Adjuvant | 11 |
| Alaska | 11 |
| Amersham | 11 |
| Army | 11 |
| Bank | 11 |
| Barr | 11 |
| Biotechnology | 11 |
| CD | 11 |
| CS | 11 |
| CXCL10 | 11 |
| Cheng | 11 |
| Marc | 11 |
| Initiative | 11 |
| Month | 11 |
| Summary | 11 |
| TNF- | 11 |
| Technology | 11 |
| Texas | 11 |
| Tris | 11 |
| Tween-20 | 11 |
| U | 11 |
| UQ | 11 |
| XhoI | 11 |
| baculovirus | 11 |
| control | 11 |
| h. | 11 |
| influenza | 11 |
| metapneumovirus | 11 |
| nucleoprotein | 11 |
| poly | 11 |
| Mouse | 11 |
| signi | 11 |
| TNF | 11 |
| Wolbachia | 11 |
| Student | 11 |
| Philippines | 11 |
| NHP | 11 |
| SPSS | 11 |
| Organisation | 11 |
| PI | 11 |
| PLGA | 11 |
| Pacific | 11 |
| Pandemic | 11 |
| Northern | 11 |
| Polio | 11 |
| SPR | 11 |
| Primary | 11 |
| Promega | 11 |
| Propionibacterium | 11 |
| Regulatory | 11 |
| SCR | 11 |
| February | 10 |
| Flaviviruses | 10 |
| FluBlØk | 10 |
| GSK | 10 |
| Greece | 10 |
| HA1 | 10 |
| HEK | 10 |
| HRSA | 10 |
| Haemophilus | 10 |
| IL-5 | 10 |
| ICS | 10 |
| IL-1 | 10 |
| FL | 10 |
| IP | 10 |
| IV | 10 |
| Immune | 10 |
| Innovations | 10 |
| Intranasal | 10 |
| Jordan | 10 |
| Fc+MF59 | 10 |
| Bernoulli | 10 |
| F11-MVA | 10 |
| Economic | 10 |
| Leask | 10 |
| ASCs | 10 |
| Butantan | 10 |
| CD26 | 10 |
| CD35 | 10 |
| CPV-2a | 10 |
| CSF | 10 |
| Chapman | 10 |
| Children | 10 |
| Chile | 10 |
| ChimeriVax | 10 |
| CoVs | 10 |
| College | 10 |
| Commission | 10 |
| Dulbecco | 10 |
| EEV | 10 |
| EI | 10 |
| LC16 | 10 |
| arboviral | 10 |
| Leghorn | 10 |
| St. | 10 |
| T7 | 10 |
| TMB | 10 |
| TMC | 10 |
| Thomas | 10 |
| Toll | 10 |
| VACV | 10 |
| Yang | 10 |
| bocavirus | 10 |
| corona | 10 |
| ed | 10 |
| endosomal | 10 |
| lymphopenia | 10 |
| mH5-MVA | 10 |
| rotaviruses | 10 |
| ts | 10 |
| ∼115 | 10 |
| Measles | 10 |
| Sun | 10 |
| Zhang | 10 |
| Smith | 10 |
| OspA | 10 |
| MedImmune | 10 |
| SEM | 10 |
| NNT | 10 |
| NYCBH | 10 |
| Nations | 10 |
| November | 10 |
| OM | 10 |
| Ohio | 10 |
| Number | 10 |
| PE | 10 |
| Pneumococcal | 10 |
| Reference | 10 |
| Progress | 10 |
| Poland | 10 |
| Project | 10 |
| Pfizer | 10 |
| Pearson | 10 |
| E2 | 9 |
| Co. | 9 |
| Community | 9 |
| Countries | 9 |
| Cross | 9 |
| DPT | 9 |
| DTP | 9 |
| DUVV | 9 |
| Dickinson | 9 |
| IgY | 9 |
| Experiment | 9 |
| Fund | 9 |
| Gao | 9 |
| George | 9 |
| Golgi | 9 |
| Guérin | 9 |
| IIV | 9 |
| IL2 | 9 |
| CR2 | 9 |
| Central | 9 |
| 3D | 9 |
| CPV | 9 |
| Bacillus | 9 |
| MHG | 9 |
| A(H1N1 | 9 |
| ANOVA | 9 |
| Ab | 9 |
| Access | 9 |
| Ad26.ZEBOV | 9 |
| Agricultural | 9 |
| Antigen | 9 |
| Banfield | 9 |
| CPRG | 9 |
| Becton | 9 |
| Biologics | 9 |
| Blue | 9 |
| Buffer | 9 |
| CCL2 | 9 |
| CER | 9 |
| CHIKV | 9 |
| CHMP | 9 |
| Log | 9 |
| isotypes | 9 |
| MN | 9 |
| disease | 9 |
| Structure | 9 |
| Studies | 9 |
| TDV | 9 |
| Technologies | 9 |
| Th2-type | 9 |
| Trial | 9 |
| Tropical | 9 |
| Zhao | 9 |
| doc_id | 9 |
| Strategic | 9 |
| ds | 9 |
| trans | 9 |
| lL | 9 |
| mouse | 9 |
| nan | 9 |
| pVSV | 9 |
| rabies | 9 |
| MOKV | 9 |
| Strategy | 9 |
| fox | 9 |
| Stockholm | 9 |
| Post | 9 |
| Southern | 9 |
| Merck | 9 |
| NP43 | 9 |
| NP44 | 9 |
| O157 | 9 |
| PNGase | 9 |
| Panel | 9 |
| Peptide | 9 |
| PFU | 9 |
| Procedure | 9 |
| RVNA | 9 |
| SCT | 9 |
| SR | 9 |
| Sabin | 9 |
| Sendai | 9 |
| Social | 9 |
| Prof. | 9 |
| Solution | 9 |
| Flaviviridae | 8 |
| Hercules | 8 |
| HA2 | 8 |
| H1N1pdm09 | 8 |
| Grant | 8 |
| GE | 8 |
| FI | 8 |
| Field | 8 |
| Fever | 8 |
| Experts | 8 |
| Huh-7 | 8 |
| Expanded | 8 |
| High | 8 |
| LMIC | 8 |
| IL-17 | 8 |
| Ikeda | 8 |
| Impact | 8 |
| Island | 8 |
| James | 8 |
| John | 8 |
| Kim | 8 |
| LDH | 8 |
| LDs | 8 |
| MW | 8 |
| Mark | 8 |
| Medium | 8 |
| Env | 8 |
| Ethics | 8 |
| Assembly | 8 |
| Emerging | 8 |
| Eagle | 8 |
| A/ | 8 |
| Act | 8 |
| Adults | 8 |
| Ae | 8 |
| Agriculture | 8 |
| Application | 8 |
| Mexico | 8 |
| AvF | 8 |
| BJ-01 | 8 |
| BRAVATO | 8 |
| BamHI | 8 |
| Bill | 8 |
| Bureau | 8 |
| CD59 | 8 |
| COPD | 8 |
| California | 8 |
| Christopher | 8 |
| Collection | 8 |
| Comparative | 8 |
| Coronaviridae | 8 |
| Culture | 8 |
| DTaP | 8 |
| Design | 8 |
| Director | 8 |
| EM | 8 |
| Methodology | 8 |
| IACUC | 8 |
| MoH | 8 |
| mosaic | 8 |
| Virology | 8 |
| adjuvant | 8 |
| catarrhalis | 8 |
| der | 8 |
| dhFr− | 8 |
| fever | 8 |
| gp120 | 8 |
| haemagglutinin | 8 |
| homogenate | 8 |
| lentiviral | 8 |
| measles | 8 |
| monocyte | 8 |
| n.a | 8 |
| VIAA | 8 |
| p.o | 8 |
| p3 | 8 |
| pIS | 8 |
| rH120 | 8 |
| reovirus | 8 |
| rst | 8 |
| sars | 8 |
| serodiagnosis | 8 |
| titre | 8 |
| xxx | 8 |
| −70 | 8 |
| Modified | 8 |
| VN/1203/04 | 8 |
| oculonasal | 8 |
| V3526 | 8 |
| Rio | 8 |
| NRAs | 8 |
| TLR-9 | 8 |
| NS1 | 8 |
| Norwalk | 8 |
| Norway | 8 |
| ONPG | 8 |
| One | 8 |
| PC3 | 8 |
| PER.C6 | 8 |
| Peru | 8 |
| Peter | 8 |
| Richard | 8 |
| Oxford | 8 |
| Spike | 8 |
| Sindbis | 8 |
| Standards | 8 |
| Standard | 8 |
| Splenocytes | 8 |
| Speed | 8 |
| Sudan | 8 |
| Serologic | 8 |
| Section | 8 |
| SNP | 8 |
| SIVgag | 8 |
| SAEs | 8 |
| Humoral | 7 |
| Guidelines | 7 |
| HZV | 7 |
| HCV | 7 |
| HBSS | 7 |
| GΔ28 | 7 |
| Guinea | 7 |
| Fast | 7 |
| Fort | 7 |
| Green | 7 |
| Genbank | 7 |
| García | 7 |
| GC | 7 |
| First | 7 |
| Force | 7 |
| ID | 7 |
| IAB | 7 |
| Material | 7 |
| IL-7 | 7 |
| MLV+/− | 7 |
| Model | 7 |
| FECV | 7 |
| Mix | 7 |
| Michael | 7 |
| Medicines | 7 |
| Mann | 7 |
| MEM | 7 |
| IPD | 7 |
| Lin | 7 |
| Lassa | 7 |
| Jackson | 7 |
| Immunizations | 7 |
| IVB | 7 |
| ITT | 7 |
| FIM | 7 |
| Acambis | 7 |
| Establishment | 7 |
| AddaVax | 7 |
| Bangladesh | 7 |
| BHK21 | 7 |
| Arrangement | 7 |
| Applied | 7 |
| Antibodies | 7 |
| Ag | 7 |
| AS01 | 7 |
| CAM | 7 |
| ARR | 7 |
| A59 | 7 |
| 8) | 7 |
| 6His | 7 |
| 2c | 7 |
| N227 | 7 |
| Burden | 7 |
| CD55 | 7 |
| Enhancement | 7 |
| Conceptualization | 7 |
| Egypt | 7 |
| ETEC | 7 |
| EGFP | 7 |
| EDTA | 7 |
| EBV | 7 |
| Duane | 7 |
| Complement | 7 |
| CD69 | 7 |
| Colombia | 7 |
| City | 7 |
| Caco-2 | 7 |
| CR3 | 7 |
| CPs | 7 |
| CDV | 7 |
| N223 | 7 |
| Southeast | 7 |
| N317 | 7 |
| Task | 7 |
| burnetii | 7 |
| amoxicillin | 7 |
| alphavirus | 7 |
| Zeiss | 7 |
| Yan | 7 |
| Xu | 7 |
| X | 7 |
| Wu | 7 |
| Whitney | 7 |
| Welfare | 7 |
| WR | 7 |
| Vesicular | 7 |
| Vaxigrip | 7 |
| V | 7 |
| Universal | 7 |
| chagasi | 7 |
| chicken | 7 |
| cytomegalovirus | 7 |
| pseudovirus | 7 |
| −1 | 7 |
| NY99 | 7 |
| ° | 7 |
| van | 7 |
| type | 7 |
| s0264 | 7 |
| propiolactone | 7 |
| health | 7 |
| pleconaril | 7 |
| pS | 7 |
| novo | 7 |
| neutrophilia | 7 |
| multimethods | 7 |
| hyperimmune | 7 |
| Total | 7 |
| infantum | 7 |
| TLRs | 7 |
| Pac | 7 |
| Practice | 7 |
| Poxvirus | 7 |
| Plasmid | 7 |
| PharMingen | 7 |
| Pathogenicity | 7 |
| Pathogenesis | 7 |
| PMA | 7 |
| Quality | 7 |
| PIV1 | 7 |
| P&I | 7 |
| Ov | 7 |
| TBS | 7 |
| Nelson | 7 |
| Outbreak | 7 |
| Products | 7 |
| Part | 7 |
| RPXV | 7 |
| SI | 7 |
| Staphylococcus | 7 |
| RR | 7 |
| Sac | 7 |
| SVRG | 7 |
| SNPs | 7 |
| SIVmac239 | 7 |
| SVDV | 7 |
| SD | 7 |
| SAS | 7 |
| Robert | 7 |
| Risk | 7 |
| Reed | 7 |
| Strain | 7 |
| HCl | 6 |
| GAP | 6 |
| HBV | 6 |
| Gubler | 6 |
| Good | 6 |
| HEPES | 6 |
| Genome | 6 |
| Gates | 6 |
| GYISTRVEL | 6 |
| GAVI | 6 |
| Finland | 6 |
| French | 6 |
| Foot | 6 |
| F11L | 6 |
| Fluvax | 6 |
| Flow | 6 |
| Facility | 6 |
| FFU | 6 |
| FFA | 6 |
| Harlan | 6 |
| FCS | 6 |
| HPLC | 6 |
| Intervet | 6 |
| Hygiene | 6 |
| Instruments | 6 |
| Level | 6 |
| Emergency | 6 |
| Lee | 6 |
| Johnson | 6 |
| Jiangsu | 6 |
| Janeiro | 6 |
| Isolation | 6 |
| Intracellular | 6 |
| Interaction | 6 |
| Innovation | 6 |
| IAV | 6 |
| Infection | 6 |
| Immunisation | 6 |
| IVS | 6 |
| INS | 6 |
| IMVAMUNE | 6 |
| IMV | 6 |
| IL-7R | 6 |
| ICD-9 | 6 |
| ICD-10 | 6 |
| Experimental | 6 |
| Age | 6 |
| Education | 6 |
| AVMA | 6 |
| BioRad | 6 |
| Bell | 6 |
| BMI | 6 |
| BMGF | 6 |
| BEA | 6 |
| Australian | 6 |
| AscI | 6 |
| Anna | 6 |
| African | 6 |
| AEs | 6 |
| Editing | 6 |
| AD20Gold | 6 |
| AD11.10 | 6 |
| ACT | 6 |
| AB | 6 |
| A2 | 6 |
| 3b | 6 |
| 2B | 6 |
| -2 | 6 |
| M1 | 6 |
| Black | 6 |
| Blueprint | 6 |
| Bluetongue | 6 |
| Borrelia | 6 |
| EER | 6 |
| E1 | 6 |
| Developing | 6 |
| Congo | 6 |
| Con | 6 |
| Comparison | 6 |
| Company | 6 |
| Choice | 6 |
| Chikungunya | 6 |
| Chiba | 6 |
| Characteristics | 6 |
| Chang | 6 |
| Chandipura | 6 |
| Census | 6 |
| Caledonia/20/99 | 6 |
| CYD | 6 |
| CVA | 6 |
| CO | 6 |
| CD19 | 6 |
| Life | 6 |
| Co | 6 |
| MERS- | 6 |
| USPSTF | 6 |
| Windows | 6 |
| Willingness | 6 |
| Wilcoxon | 6 |
| Washington | 6 |
| Warp | 6 |
| Wales | 6 |
| WIV | 6 |
| WG3 | 6 |
| Vaccinomics | 6 |
| Turkey | 6 |
| brome | 6 |
| Times | 6 |
| Th1-type | 6 |
| Tel | 6 |
| Tdap | 6 |
| TX | 6 |
| TND | 6 |
| TC-6 | 6 |
| T67 | 6 |
| Sv | 6 |
| antigen(s | 6 |
| cDNA | 6 |
| St | 6 |
| mycobacterial | 6 |
| MERSpp | 6 |
| À80 | 6 |
| west | 6 |
| pandemic | 6 |
| pT.gp | 6 |
| pNG3041(MSA2-Cov | 6 |
| pBS | 6 |
| ovalbumin | 6 |
| ned | 6 |
| multicentre | 6 |
| choanal | 6 |
| monkeypox | 6 |
| middle | 6 |
| mastoiditis | 6 |
| mac239 | 6 |
| human | 6 |
| hla | 6 |
| goat | 6 |
| east | 6 |
| cis | 6 |
| Subbarao | 6 |
| donovani | 6 |
| Spier | 6 |
| NS2B | 6 |
| Package | 6 |
| PVDF | 6 |
| PIV | 6 |
| PCV7 | 6 |
| Otitis | 6 |
| Operation | 6 |
| ODN | 6 |
| Northeast | 6 |
| Norovirus | 6 |
| Membrane | 6 |
| Park | 6 |
| Melinda | 6 |
| Martin | 6 |
| Maria | 6 |
| Manufacturers | 6 |
| MRSA | 6 |
| MRC | 6 |
| MPs | 6 |
| Snodgrass | 6 |
| MF59-adjuvanted | 6 |
| Paris | 6 |
| Newcastle | 6 |
| Peak | 6 |
| Reporting | 6 |
| Shanghai | 6 |
| Season | 6 |
| PhD | 6 |
| Schwarz | 6 |
| SRIP | 6 |
| SN | 6 |
| SF2 | 6 |
| S.D. | 6 |
| S(TR2 | 6 |
| River | 6 |
| SE | 6 |
| Pneumonia | 6 |
| Pharmaceuticals | 6 |
| RBD+MF59 | 6 |
| RBC | 6 |
| Province | 6 |
| Press | 6 |
| Poultry | 6 |
| RV | 6 |
| IBYZ/2011 | 5 |
| ICR | 5 |
| Immunology | 5 |
| IL-15 | 5 |
| ISA-51 | 5 |
| IgY. | 5 |
| IVR | 5 |
| IgG. | 5 |
| IgG2b | 5 |
| IgG3 | 5 |
| Huang | 5 |
| IBM | 5 |
| H5N1-specific | 5 |
| House | 5 |
| Host | 5 |
| Hib | 5 |
| Hesitancy | 5 |
| Henipavirus | 5 |
| Helicobacter | 5 |
| HPAI | 5 |
| HHS | 5 |
| H-2 | 5 |
| Guide | 5 |
| Jiang | 5 |
| Groups | 5 |
| Industry | 5 |
| Marie | 5 |
| KB8523 | 5 |
| KSCN | 5 |
| GMO | 5 |
| Military | 5 |
| Microsoft | 5 |
| Mechanisms | 5 |
| Mass | 5 |
| Maryland | 5 |
| Marek | 5 |
| Manitoba | 5 |
| Malhame | 5 |
| Macaca | 5 |
| MSgp7 | 5 |
| MSA2-specific | 5 |
| MR | 5 |
| Lymphopenia | 5 |
| Los | 5 |
| Long | 5 |
| London1 | 5 |
| LiESAp | 5 |
| Latin | 5 |
| Lanka | 5 |
| Lagos | 5 |
| L3 | 5 |
| Kit | 5 |
| Karber | 5 |
| Kanta | 5 |
| Groll | 5 |
| Annual | 5 |
| GM1 | 5 |
| GL | 5 |
| CD18 | 5 |
| CD11c | 5 |
| CD11b | 5 |
| C9 | 5 |
| C(D28 | 5 |
| Biosystems | 5 |
| Biosafety | 5 |
| Bethesda | 5 |
| Beckman | 5 |
| Balanced | 5 |
| BCIP | 5 |
| BAL | 5 |
| Authority | 5 |
| Associations | 5 |
| Associated | 5 |
| Moraxella | 5 |
| Angeles | 5 |
| Adenoviral | 5 |
| AUG | 5 |
| ASF | 5 |
| A20-EGFP | 5 |
| 4B | 5 |
| 3c | 5 |
| 2a | 5 |
| -3 | 5 |
| CT | 5 |
| Campaign | 5 |
| Canarypox | 5 |
| Diagnostics | 5 |
| Franklin | 5 |
| FeLV | 5 |
| Ex | 5 |
| Eric | 5 |
| Emily | 5 |
| Elizabeth | 5 |
| ESEN | 5 |
| E3 | 5 |
| Dutch | 5 |
| Dodge | 5 |
| Discrete | 5 |
| Diagnostic | 5 |
| Carlsbad | 5 |
| Davis | 5 |
| Darby | 5 |
| DPI | 5 |
| Crouch | 5 |
| Covid-19 | 5 |
| Coverage | 5 |
| Corp. | 5 |
| Coomassie | 5 |
| Charles | 5 |
| Chain | 5 |
| Cell | 5 |
| Minneapolis | 5 |
| Herpes | 5 |
| Muench | 5 |
| Tcell | 5 |
| ck | 5 |
| bOPV | 5 |
| antisera | 5 |
| administration | 5 |
| Yuan | 5 |
| Yi | 5 |
| Yersinia | 5 |
| Y. | 5 |
| Y | 5 |
| XbaI | 5 |
| Workshop | 5 |
| Vietnam | 5 |
| Vet | 5 |
| VT | 5 |
| V. | 5 |
| Uruguay | 5 |
| UN | 5 |
| U.S.A. | 5 |
| Trump | 5 |
| Trizol | 5 |
| Trials | 5 |
| Treatment | 5 |
| Toronto | 5 |
| Thomson | 5 |
| Tergitol | 5 |
| dpc | 5 |
| dpi | 5 |
| dpv | 5 |
| mice | 5 |
| NBT | 5 |
| ≤−60 | 5 |
| γ | 5 |
| wt./vol | 5 |
| von | 5 |
| square | 5 |
| saponaria | 5 |
| reo | 5 |
| qPCR | 5 |
| pI | 5 |
| myxomatosis | 5 |
| merozoite | 5 |
| eBioscience | 5 |
| institute | 5 |
| inactivant | 5 |
| immunosenescence | 5 |
| immunodominant | 5 |
| hACE2 | 5 |
| guinea | 5 |
| gp160 | 5 |
| fluid | 5 |
| eosin | 5 |
| enterotoxigenic | 5 |
| eld | 5 |
| Team | 5 |
| nisin | 5 |
| Taipei | 5 |
| QBI-293A | 5 |
| PrtP | 5 |
| Preventive | 5 |
| Preferred | 5 |
| Prediction | 5 |
| Population | 5 |
| Policy | 5 |
| Platform | 5 |
| Pierce | 5 |
| Petersburg | 5 |
| Peng | 5 |
| Patients | 5 |
| Paramyxoviridae | 5 |
| PR/8/34 | 5 |
| PQ | 5 |
| PP | 5 |
| PK-15 | 5 |
| PEG | 5 |
| Onchocerca | 5 |
| Nunc | 5 |
| NotI | 5 |
| Ni | 5 |
| Neisseria | 5 |
| NV | 5 |
| TW2296/95 | 5 |
| NF | 5 |
| Puerto | 5 |
| Novartis | 5 |
| RG | 5 |
| Salt | 5 |
| TDM | 5 |
| RIP | 5 |
| TLR-4 | 5 |
| TC | 5 |
| Step | 5 |
| Statistics | 5 |
| Sri | 5 |
| Spearman | 5 |
| Society | 5 |
| Sinergium | 5 |
| Senegal | 5 |
| Systematic | 5 |
| ST3 | 5 |
| Rev | 5 |
| Rabbit | 5 |
| Receptor | 5 |
| SIG | 5 |
| Ref | 5 |
| Response | 5 |
| Recommendations | 5 |
| Roche | 5 |
| Rotavirus | 5 |
| Revolving | 5 |
| SFU | 5 |
| IAP | 4 |
| HRV | 4 |
| Graham | 4 |
| ICH | 4 |
| Great | 4 |
| Grijalva | 4 |
| Guillain | 4 |
| Gurwith | 4 |
| H&E | 4 |
| H2-K | 4 |
| HEp-2 | 4 |
| HTCC | 4 |
| HVTN | 4 |
| Hall | 4 |
| Han | 4 |
| Hank | 4 |
| Harmonisation | 4 |
| Holstein | 4 |
| Hopkins | 4 |
| Horizonte | 4 |
| GmbH | 4 |
| Grace | 4 |
| FluMist | 4 |
| Glo | 4 |
| Feline | 4 |
| Erasmus | 4 |
| IFNc | 4 |
| Ethical | 4 |
| Eudragit | 4 |
| Excel | 4 |
| FAO | 4 |
| FLs | 4 |
| 4 | |
| Family | 4 |
| Figs | 4 |
| Genomic | 4 |
| FlowJo | 4 |
| Focus | 4 |
| FoxP3 | 4 |
| Frederick | 4 |
| Frey | 4 |
| G1 | 4 |
| GP | 4 |
| GZ-01 | 4 |
| Gaithersburg | 4 |
| ICMJE | 4 |
| Le | 4 |
| IN | 4 |
| MWCO | 4 |
| Lipofectamine | 4 |
| Lynn | 4 |
| Lyssavirus | 4 |
| MAC | 4 |
| MARC-145 | 4 |
| MCP-1 | 4 |
| ME | 4 |
| MFI | 4 |
| MRC-5 | 4 |
| Macaque | 4 |
| IP-10 | 4 |
| Madin | 4 |
| Maldives | 4 |
| Marennikova | 4 |
| Matthew | 4 |
| Measurement | 4 |
| Mechanism | 4 |
| Medicinal | 4 |
| Microbiology | 4 |
| Enterovirus | 4 |
| Lab | 4 |
| LX4-type | 4 |
| LALLLLDRL | 4 |
| L1 | 4 |
| IS | 4 |
| IgE | 4 |
| IgK | 4 |
| Inaktivierung | 4 |
| Infections | 4 |
| Iowa | 4 |
| Israel | 4 |
| J.K. | 4 |
| Jab | 4 |
| Janssen | 4 |
| Jean | 4 |
| Jolla | 4 |
| Jonathan | 4 |
| Jose | 4 |
| Juan | 4 |
| Julia | 4 |
| K1 | 4 |
| KPL | 4 |
| Keuls | 4 |
| Equivac | 4 |
| CD107a | 4 |
| English | 4 |
| BioTek | 4 |
| B19 | 4 |
| BRSV | 4 |
| BSL3 | 4 |
| Bahnemann | 4 |
| Baxter | 4 |
| Belo | 4 |
| Benefit | 4 |
| Bharat | 4 |
| Binding | 4 |
| Bright | 4 |
| CV | 4 |
| Brown | 4 |
| C5 | 4 |
| C6/36 | 4 |
| CD154 | 4 |
| CD4(+ | 4 |
| CD44 | 4 |
| CD49b | 4 |
| CEF | 4 |
| CT6 | 4 |
| Araç | 4 |
| Approval | 4 |
| Anthony | 4 |
| Angola | 4 |
| Mini | 4 |
| -410X/ | 4 |
| -7 | 4 |
| 17D | 4 |
| 1B | 4 |
| 1a | 4 |
| 3d | 4 |
| 6C | 4 |
| A(H3N2 | 4 |
| A(H7N9 | 4 |
| AEFI | 4 |
| Accession | 4 |
| AcmA | 4 |
| Ad35 | 4 |
| Aflll | 4 |
| Alabama | 4 |
| Alphavirus | 4 |
| Alum | 4 |
| Andrew | 4 |
| CTC | 4 |
| CV2 | 4 |
| Ebolavirus | 4 |
| Deglycosylation | 4 |
| Cytotoxic | 4 |
| D207 | 4 |
| DG44 | 4 |
| DHFR | 4 |
| DT | 4 |
| DTT | 4 |
| De | 4 |
| Deborah | 4 |
| Deehan | 4 |
| Delivery | 4 |
| CaP | 4 |
| Delmarva | 4 |
| Denny | 4 |
| Douglas | 4 |
| Dynamics | 4 |
| EC | 4 |
| ED | 4 |
| EMEA | 4 |
| ES-62 | 4 |
| ESO-1 | 4 |
| Cytomegalovirus | 4 |
| Culicoides | 4 |
| Crystal | 4 |
| Cox | 4 |
| Cells | 4 |
| Cerda | 4 |
| Characterisation | 4 |
| Cherry | 4 |
| Chia | 4 |
| Child | 4 |
| Chlamydia | 4 |
| Chu | 4 |
| Clinic | 4 |
| Clone | 4 |
| Colorado | 4 |
| Columbia | 4 |
| Condit | 4 |
| Construction | 4 |
| Containment | 4 |
| Cooperative | 4 |
| Coparvax | 4 |
| Copenhagen | 4 |
| Coronaviruses | 4 |
| Microplate | 4 |
| Winooski | 4 |
| Models | 4 |
| ca | 4 |
| Workers | 4 |
| Yoon | 4 |
| ZEBOV | 4 |
| Zhou | 4 |
| acnes | 4 |
| am-1 | 4 |
| arctic | 4 |
| arterivirus | 4 |
| atuba | 4 |
| chi | 4 |
| ☐ | 4 |
| chorioallantoic | 4 |
| cleft | 4 |
| costimulatory | 4 |
| coxsackievirus | 4 |
| dpp | 4 |
| enteroviruses | 4 |
| flaviviral | 4 |
| flexneri | 4 |
| gal | 4 |
| Wood | 4 |
| Wilson | 4 |
| TNFa | 4 |
| Urbani | 4 |
| Tampa | 4 |
| Tan | 4 |
| Tang | 4 |
| Tanzania | 4 |
| Triton | 4 |
| Trust | 4 |
| 4 | |
| UCI | 4 |
| USAMRDC | 4 |
| VIS | 4 |
| Wellcome | 4 |
| VL | 4 |
| Vaccinology | 4 |
| Valencia | 4 |
| Visualization | 4 |
| Vol | 4 |
| WA | 4 |
| WB | 4 |
| WN | 4 |
| WNE | 4 |
| gp120-CD4 | 4 |
| group | 4 |
| hDPP4-Tg | 4 |
| susCHO | 4 |
| prM | 4 |
| protein-1 | 4 |
| pseudotyped | 4 |
| rIFN | 4 |
| rhinotracheitis | 4 |
| serosurveillance | 4 |
| soit | 4 |
| spots/10 | 4 |
| streptavidin | 4 |
| turkey | 4 |
| hematoxylin | 4 |
| und | 4 |
| vTF7 | 4 |
| vol./vol | 4 |
| xxxx | 4 |
| © | 4 |
| Ø | 4 |
| −5 | 4 |
| △ | 4 |
| Monath | 4 |
| polyprotein | 4 |
| pestivirus | 4 |
| perforin | 4 |
| para | 4 |
| herpesviruses | 4 |
| https:// | 4 |
| i | 4 |
| kg | 4 |
| leprosin | 4 |
| lgG | 4 |
| lm | 4 |
| lyssaviruses | 4 |
| mM | 4 |
| macaque | 4 |
| melitensis | 4 |
| modi | 4 |
| myopericarditis | 4 |
| nAb | 4 |
| nef | 4 |
| neurotropic | 4 |
| nsp2 | 4 |
| pES | 4 |
| pISBS | 4 |
| Tables | 4 |
| trimeric | 4 |
| TLR2 | 4 |
| Pathogen | 4 |
| OPT | 4 |
| PIP | 4 |
| PRK | 4 |
| PRRs | 4 |
| PTox | 4 |
| PV-11 | 4 |
| Pakistan | 4 |
| Pan | 4 |
| Parvovirus | 4 |
| Pathology | 4 |
| Polymerase | 4 |
| Patricia | 4 |
| Paul | 4 |
| PcO.05 | 4 |
| Pediatric | 4 |
| Peromyscus | 4 |
| Pertussis | 4 |
| Pharma | 4 |
| Philo | 4 |
| Ping | 4 |
| ONRAB | 4 |
| O. | 4 |
| Nosocomial | 4 |
| Nikon | 4 |
| Mononegavirales | 4 |
| TGE | 4 |
| Montanide | 4 |
| Moreau | 4 |
| Mouth | 4 |
| NCBI | 4 |
| NHPs | 4 |
| NHS | 4 |
| NKT | 4 |
| Na | 4 |
| NaCl | 4 |
| NaOH | 4 |
| Nagasaki | 4 |
| Native | 4 |
| Nco | 4 |
| Newman | 4 |
| News | 4 |
| NheI | 4 |
| Nigeria | 4 |
| Polyclonal | 4 |
| ND | 4 |
| Populations | 4 |
| Seasonal | 4 |
| Roy | 4 |
| Rural | 4 |
| SAD | 4 |
| SAH | 4 |
| SCV | 4 |
| SH | 4 |
| Saharan | 4 |
| Scotland | 4 |
| Scott | 4 |
| Secretariat | 4 |
| Rockford | 4 |
| Sepharose | 4 |
| Sheng | 4 |
| Shi | 4 |
| Sino | 4 |
| Supp | 4 |
| Support | 4 |
| Position | 4 |
| TCID50 | 4 |
| Syncytial | 4 |
| Rome | 4 |
| Superior | 4 |
| Robertson | 4 |
| Potential | 4 |
| Roberts | 4 |
| Process | 4 |
| Probes | 4 |
| Protective | 4 |
| RB51 | 4 |
| RD | 4 |
| RE | 4 |
| RNeasy | 4 |
| Production | 4 |
| RV144 | 4 |
| Replication | 4 |
| Robbins | 4 |
| Randomized | 4 |
| Requirements | 4 |
| Requirement | 4 |
| Procedures | 4 |
| Rat | 4 |
| Regulations | 4 |
| Region | 4 |
| Fusion | 3 |
| HDCV | 3 |
| HCW | 3 |
| HBsAg | 3 |
| H9N2 | 3 |
| H1 | 3 |
| Gupta | 3 |
| Guideline | 3 |
| Guangxi | 3 |
| Guerin | 3 |
| HEK293T | 3 |
| Graphpad | 3 |
| Graph | 3 |
| Glycoprotein | 3 |
| Glu | 3 |
| GLA | 3 |
| GIBCO | 3 |
| Grand | 3 |
| Hao | 3 |
| HFMD | 3 |
| Heinz | 3 |
| Horn | 3 |
| Home | 3 |
| Formalin | 3 |
| Histopathology | 3 |
| Histopathological | 3 |
| Herpesviruses | 3 |
| Herald | 3 |
| Hemagglutinin | 3 |
| Hashizume | 3 |
| HKU-39849 | 3 |
| Harris | 3 |
| Happer | 3 |
| Hanson | 3 |
| Hansen | 3 |
| Ham | 3 |
| HPV-16 | 3 |
| HPIV | 3 |
| HNE | 3 |
| Foxp3 | 3 |
| Evans | 3 |
| Formal | 3 |
| El | 3 |
| Eq | 3 |
| Epitopes | 3 |
| Epitope | 3 |
| Environmental | 3 |
| Entry | 3 |
| Enhanced | 3 |
| Engineering | 3 |
| Elimination | 3 |
| Effector | 3 |
| Forecast | 3 |
| Edward | 3 |
| Editor | 3 |
| Earthquake | 3 |
| EVD | 3 |
| ETVAX | 3 |
| EMC/2012 | 3 |
| Hu | 3 |
| EIA | 3 |
| Eradication | 3 |
| Eubiologics | 3 |
| Eur | 3 |
| Excler | 3 |
| Fiona | 3 |
| Ficoll | 3 |
| Felber | 3 |
| Fehr | 3 |
| Federation | 3 |
| Federal | 3 |
| Fcγ | 3 |
| Fc- | 3 |
| Farms | 3 |
| Fan | 3 |
| Facs | 3 |
| Fab | 3 |
| FIV | 3 |
| F1-V | 3 |
| F-68 | 3 |
| Expression | 3 |
| Executive | 3 |
| Hours | 3 |
| LDL/04II | 3 |
| Humans | 3 |
| Likert | 3 |
| Lyon | 3 |
| Lung | 3 |
| Luminex | 3 |
| Lu | 3 |
| Lowry | 3 |
| Low | 3 |
| Louise | 3 |
| Location | 3 |
| Liberia | 3 |
| IBV5 | 3 |
| Leu | 3 |
| Leipzig | 3 |
| Laemmli | 3 |
| Labour | 3 |
| LSR | 3 |
| LN | 3 |
| LK | 3 |
| LHLJ/04V. | 3 |
| Lys | 3 |
| Lysosomal | 3 |
| M41U | 3 |
| MA-104 | 3 |
| E6-based | 3 |
| Maul | 3 |
| Materials | 3 |
| Master | 3 |
| Marketing | 3 |
| Market | 3 |
| Marburgvirus | 3 |
| Man | 3 |
| Malaria | 3 |
| Mahmoud | 3 |
| Ma | 3 |
| MRV | 3 |
| MML | 3 |
| MLL | 3 |
| MICA | 3 |
| MDP | 3 |
| MBL | 3 |
| LCL | 3 |
| Kyu | 3 |
| KpnI | 3 |
| Interferon | 3 |
| Inovio | 3 |
| Indianapolis | 3 |
| Income | 3 |
| Immunotherapy | 3 |
| Illumina | 3 |
| IgMs | 3 |
| IgA. | 3 |
| IVI | 3 |
| ISs | 3 |
| IPAC | 3 |
| ILIAD | 3 |
| IL-9 | 3 |
| IL-8 | 3 |
| IL-12p40 | 3 |
| IIb | 3 |
| IFU | 3 |
| IE | 3 |
| Inspection | 3 |
| Interview | 3 |
| Koch | 3 |
| Investment | 3 |
| Klauenseuche | 3 |
| Kenya | 3 |
| Karl | 3 |
| KUNV | 3 |
| KPEDV-9 | 3 |
| KMC | 3 |
| K99 | 3 |
| Jun | 3 |
| Joseph | 3 |
| Joint | 3 |
| Johns | 3 |
| Joao | 3 |
| Jenner | 3 |
| Jackwood | 3 |
| JHM | 3 |
| Issue | 3 |
| Isotype | 3 |
| ECBS | 3 |
| Bosco | 3 |
| Dwivedi | 3 |
| BS | 3 |
| Bedford | 3 |
| Batson | 3 |
| Based | 3 |
| Barbara | 3 |
| Bar | 3 |
| Bacteriology | 3 |
| BSL-3 | 3 |
| BSL | 3 |
| BMDC | 3 |
| Du | 3 |
| BIO | 3 |
| BDV | 3 |
| BC | 3 |
| BALBC | 3 |
| B/ | 3 |
| Azu | 3 |
| Authorisation | 3 |
| Assay | 3 |
| Bele | 3 |
| Belisle | 3 |
| Bellinzoni | 3 |
| BigDye | 3 |
| Bunyaviridae | 3 |
| BsaI | 3 |
| Brunswick | 3 |
| British | 3 |
| Britain | 3 |
| Brasil | 3 |
| Meade | 3 |
| Bonferroni | 3 |
| Boehringer | 3 |
| Blood | 3 |
| Birmingham | 3 |
| Bioniche | 3 |
| Biology | 3 |
| Biolabs | 3 |
| Biodistribution | 3 |
| BioNet | 3 |
| Billerica | 3 |
| Array | 3 |
| Arginine | 3 |
| Arabian | 3 |
| Abs | 3 |
| AMPVs | 3 |
| AL/4614/98 | 3 |
| AG | 3 |
| ACAM1000 | 3 |
| AAALAC | 3 |
| A20 | 3 |
| 8b | 3 |
| 7C | 3 |
| 7B | 3 |
| 5D | 3 |
| 588-Fc | 3 |
| 3QPCR | 3 |
| 2d | 3 |
| 2A | 3 |
| 1ab | 3 |
| 1E | 3 |
| -20 | 3 |
| Abcam | 3 |
| Acceptance | 3 |
| Appendix | 3 |
| Acute | 3 |
| Apo | 3 |
| Antimicrobial | 3 |
| Anova | 3 |
| Annelies | 3 |
| Ann | 3 |
| Animals | 3 |
| Amicon | 3 |
| Ambion | 3 |
| Alliance | 3 |
| Allergy | 3 |
| Alexander | 3 |
| Ags | 3 |
| Agenda | 3 |
| Affairs | 3 |
| Adversomics | 3 |
| Adolescent | 3 |
| Ad5 | 3 |
| Burlingame | 3 |
| C.F. | 3 |
| C1 | 3 |
| DPBS | 3 |
| DD | 3 |
| D64 | 3 |
| D28 | 3 |
| D26 | 3 |
| D2 | 3 |
| Cytometry | 3 |
| Cytokines | 3 |
| Cynomys | 3 |
| Cy7 | 3 |
| Culex | 3 |
| Ct | 3 |
| Cryo | 3 |
| Cruz | 3 |
| Critical | 3 |
| CpG. | 3 |
| Coxiella | 3 |
| County | 3 |
| DMSO | 3 |
| DPV | 3 |
| Costar | 3 |
| DRC | 3 |
| Draft | 3 |
| Dong | 3 |
| Document | 3 |
| Dobos | 3 |
| Discovery | 3 |
| Devices | 3 |
| Dengvaxia | 3 |
| Democratic | 3 |
| Defense | 3 |
| Declaration | 3 |
| Decaro | 3 |
| Database | 3 |
| Danish | 3 |
| Daniel | 3 |
| Daily | 3 |
| DTWG | 3 |
| DTH | 3 |
| Country | 3 |
| Controls | 3 |
| C4 | 3 |
| Caribbean | 3 |
| Cao | 3 |
| Candidate | 3 |
| Camarillo | 3 |
| CTLs | 3 |
| CTD | 3 |
| CSP | 3 |
| CSL | 3 |
| CRF | 3 |
| CRD | 3 |
| CHAI | 3 |
| CFAR | 3 |
| CF | 3 |
| CDM | 3 |
| CCR5 | 3 |
| CCR2 | 3 |
| CAS | 3 |
| CALT | 3 |
| Capsid | 3 |
| Carlo | 3 |
| Contribution | 3 |
| Cary | 3 |
| Conservation | 3 |
| Connaught | 3 |
| Conference | 3 |
| Comrie | 3 |
| Cohen | 3 |
| Clontech | 3 |
| Classification | 3 |
| Chuan | 3 |
| Chiron | 3 |
| Chinsangaram | 3 |
| Chicken | 3 |
| Chicago | 3 |
| Chengdu | 3 |
| Chemical | 3 |
| Characterization | 3 |
| CellQuest | 3 |
| Catalonia | 3 |
| Mauricio | 3 |
| Authorization | 3 |
| Media | 3 |
| Xia | 3 |
| Zagreb | 3 |
| Yorkshire | 3 |
| Yin | 3 |
| Yellow | 3 |
| YQVNNLEEI | 3 |
| YF-17D | 3 |
| Xiumei | 3 |
| Xin | 3 |
| Xho1 | 3 |
| cov | 3 |
| Wyeth | 3 |
| Wooster | 3 |
| Wit | 3 |
| Williams | 3 |
| William | 3 |
| Wilder | 3 |
| Wei | 3 |
| War | 3 |
| Zerun | 3 |
| Zhu | 3 |
| Zoonoses | 3 |
| Zoonotic | 3 |
| colostrum | 3 |
| clusterin | 3 |
| chitosans | 3 |
| china | 3 |
| author(s | 3 |
| assembly | 3 |
| antirabies | 3 |
| antibody | 3 |
| antibodies | 3 |
| animal | 3 |
| alhydrogel | 3 |
| adenoviral | 3 |
| adCHO | 3 |
| aa | 3 |
| aL | 3 |
| a4-a4 | 3 |
| Zymo | 3 |
| Walter | 3 |
| WI | 3 |
| W.C. | 3 |
| Univ | 3 |
| Ultra-15 | 3 |
| UTR | 3 |
| U.S | 3 |
| Tuskegee | 3 |
| Tukey | 3 |
| Trichosurus | 3 |
| Treg | 3 |
| Transfer | 3 |
| Transfection | 3 |
| Trans | 3 |
| Trade | 3 |
| Tissue | 3 |
| Thompson | 3 |
| Third | 3 |
| Thai | 3 |
| Th17 | 3 |
| Tetsuo | 3 |
| Unit | 3 |
| Uppsala | 3 |
| Viruses | 3 |
| VEI | 3 |
| Vila | 3 |
| Viet | 3 |
| Vectored | 3 |
| Vaxxed | 3 |
| Vax | 3 |
| Vasilakis | 3 |
| Vasee | 3 |
| Van | 3 |
| Validation | 3 |
| VYQVNNLEEIC | 3 |
| VSVΔM51-GΔ28 | 3 |
| VRC01 | 3 |
| VR2332 | 3 |
| VPM1002 | 3 |
| VMRD | 3 |
| VLPs | 3 |
| VG19 | 3 |
| convertases | 3 |
| cynomolgus | 3 |
| Td | 3 |
| polio | 3 |
| rIFNα-2b | 3 |
| rBacmid | 3 |
| pseudotypes | 3 |
| preimmune | 3 |
| postvaccination | 3 |
| post | 3 |
| polyclonal | 3 |
| poly(A | 3 |
| pm-6 | 3 |
| del | 3 |
| plasma | 3 |
| phagocyte | 3 |
| pg | 3 |
| pestis | 3 |
| peptide | 3 |
| paraformaldehyde | 3 |
| par | 3 |